Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Finding Study of Lyophilized Shigella Sonnei 53G Challenge Strain
NCT02816346Phase 1Completed
- Sponsor
- PATH
- Start
- Sep 2016
- Primary completion
- Dec 2017
- Countries
- 1
01
Overview
Phase 1, open-label trial of Shigella sonnei strain 53G in shigellosis (5 cohorts), sponsored by PATH. Primary endpoint: Number of Participants With Shigellosis at 11 days. Started Sep 2016; status: completed.
02
Drugs
Shigella sonnei strain 53G
03
Conditions
shigellosis
Beyond the preview
Go deeper on NCT02816346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02816346.